Table of Content

1 Anti-PD-1 Antibody Market Overview
1.1 Product Overview and Scope of Anti-PD-1 Antibody
1.2 Anti-PD-1 Antibody Segment by Type
1.2.1 Global Anti-PD-1 Antibody Market Value Comparison by Type (2024-2034)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Anti-PD-1 Antibody Segment by Application
1.3.1 Global Anti-PD-1 Antibody Market Value by Application: (2024-2034)
1.3.2 IHC-P
1.3.3 ICC/IF
1.3.4 WB
1.3.5 Flow Cytometry
1.3.6 ELISA
1.4 Global Anti-PD-1 Antibody Market Size Estimates and Forecasts
1.4.1 Global Anti-PD-1 Antibody Revenue 2018-2029
1.4.2 Global Anti-PD-1 Antibody Sales 2018-2029
1.4.3 Global Anti-PD-1 Antibody Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Anti-PD-1 Antibody Market Competition by Manufacturers
2.1 Global Anti-PD-1 Antibody Sales Market Share by Manufacturers (2018-2024)
2.2 Global Anti-PD-1 Antibody Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Anti-PD-1 Antibody Average Price by Manufacturers (2018-2024)
2.4 Global Anti-PD-1 Antibody Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Anti-PD-1 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-PD-1 Antibody, Product Type & Application
2.7 Anti-PD-1 Antibody Market Competitive Situation and Trends
2.7.1 Anti-PD-1 Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-PD-1 Antibody Players Market Share by Revenue
2.7.3 Global Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-PD-1 Antibody Retrospective Market Scenario by Region
3.1 Global Anti-PD-1 Antibody Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Anti-PD-1 Antibody Global Anti-PD-1 Antibody Sales by Region: 2018-2029
3.2.1 Global Anti-PD-1 Antibody Sales by Region: 2018-2024
3.2.2 Global Anti-PD-1 Antibody Sales by Region: 2024-2029
3.3 Global Anti-PD-1 Antibody Global Anti-PD-1 Antibody Revenue by Region: 2018-2029
3.3.1 Global Anti-PD-1 Antibody Revenue by Region: 2018-2024
3.3.2 Global Anti-PD-1 Antibody Revenue by Region: 2024-2029
3.4 North America Anti-PD-1 Antibody Market Facts & Figures by Country
3.4.1 North America Anti-PD-1 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Anti-PD-1 Antibody Sales by Country (2018-2029)
3.4.3 North America Anti-PD-1 Antibody Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-PD-1 Antibody Market Facts & Figures by Country
3.5.1 Europe Anti-PD-1 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Anti-PD-1 Antibody Sales by Country (2018-2029)
3.5.3 Europe Anti-PD-1 Antibody Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-PD-1 Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-PD-1 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Anti-PD-1 Antibody Sales by Country (2018-2029)
3.6.3 Asia Pacific Anti-PD-1 Antibody Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-PD-1 Antibody Market Facts & Figures by Country
3.7.1 Latin America Anti-PD-1 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Anti-PD-1 Antibody Sales by Country (2018-2029)
3.7.3 Latin America Anti-PD-1 Antibody Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-PD-1 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-PD-1 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Anti-PD-1 Antibody Sales by Country (2018-2029)
3.8.3 Middle East and Africa Anti-PD-1 Antibody Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-PD-1 Antibody Sales by Type (2018-2029)
4.1.1 Global Anti-PD-1 Antibody Sales by Type (2018-2024)
4.1.2 Global Anti-PD-1 Antibody Sales by Type (2024-2029)
4.1.3 Global Anti-PD-1 Antibody Sales Market Share by Type (2018-2029)
4.2 Global Anti-PD-1 Antibody Revenue by Type (2018-2029)
4.2.1 Global Anti-PD-1 Antibody Revenue by Type (2018-2024)
4.2.2 Global Anti-PD-1 Antibody Revenue by Type (2024-2029)
4.2.3 Global Anti-PD-1 Antibody Revenue Market Share by Type (2018-2029)
4.3 Global Anti-PD-1 Antibody Price by Type (2018-2029)
5 Segment by Application
5.1 Global Anti-PD-1 Antibody Sales by Application (2018-2029)
5.1.1 Global Anti-PD-1 Antibody Sales by Application (2018-2024)
5.1.2 Global Anti-PD-1 Antibody Sales by Application (2024-2029)
5.1.3 Global Anti-PD-1 Antibody Sales Market Share by Application (2018-2029)
5.2 Global Anti-PD-1 Antibody Revenue by Application (2018-2029)
5.2.1 Global Anti-PD-1 Antibody Revenue by Application (2018-2024)
5.2.2 Global Anti-PD-1 Antibody Revenue by Application (2024-2029)
5.2.3 Global Anti-PD-1 Antibody Revenue Market Share by Application (2018-2029)
5.3 Global Anti-PD-1 Antibody Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bio X Cell
6.1.1 Bio X Cell Corporation Information
6.1.2 Bio X Cell Description and Business Overview
6.1.3 Bio X Cell Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Bio X Cell Anti-PD-1 Antibody Product Portfolio
6.1.5 Bio X Cell Recent Developments/Updates
6.2 Thermo Fisher
6.2.1 Thermo Fisher Corporation Information
6.2.2 Thermo Fisher Description and Business Overview
6.2.3 Thermo Fisher Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Thermo Fisher Anti-PD-1 Antibody Product Portfolio
6.2.5 Thermo Fisher Recent Developments/Updates
6.3 InvivoGen
6.3.1 InvivoGen Corporation Information
6.3.2 InvivoGen Description and Business Overview
6.3.3 InvivoGen Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.3.4 InvivoGen Anti-PD-1 Antibody Product Portfolio
6.3.5 InvivoGen Recent Developments/Updates
6.4 BioVision Inc
6.4.1 BioVision Inc Corporation Information
6.4.2 BioVision Inc Description and Business Overview
6.4.3 BioVision Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.4.4 BioVision Inc Anti-PD-1 Antibody Product Portfolio
6.4.5 BioVision Inc Recent Developments/Updates
6.5 Abcam
6.5.1 Abcam Corporation Information
6.5.2 Abcam Description and Business Overview
6.5.3 Abcam Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Abcam Anti-PD-1 Antibody Product Portfolio
6.5.5 Abcam Recent Developments/Updates
6.6 Bristol-Myers Squibb (BMS)
6.6.1 Bristol-Myers Squibb (BMS) Corporation Information
6.6.2 Bristol-Myers Squibb (BMS) Description and Business Overview
6.6.3 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product Portfolio
6.6.5 Bristol-Myers Squibb (BMS) Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Merck Anti-PD-1 Antibody Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Ono Pharmaceutical Co., Ltd
6.8.1 Ono Pharmaceutical Co., Ltd Corporation Information
6.8.2 Ono Pharmaceutical Co., Ltd Description and Business Overview
6.8.3 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolio
6.8.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
6.9 Lilly
6.9.1 Lilly Corporation Information
6.9.2 Lilly Description and Business Overview
6.9.3 Lilly Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Lilly Anti-PD-1 Antibody Product Portfolio
6.9.5 Lilly Recent Developments/Updates
6.10 Chugai Pharmaceutical Co., Ltd
6.10.1 Chugai Pharmaceutical Co., Ltd Corporation Information
6.10.2 Chugai Pharmaceutical Co., Ltd Description and Business Overview
6.10.3 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolio
6.10.5 Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
6.11 BeiGene
6.11.1 BeiGene Corporation Information
6.11.2 BeiGene Anti-PD-1 Antibody Description and Business Overview
6.11.3 BeiGene Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.11.4 BeiGene Anti-PD-1 Antibody Product Portfolio
6.11.5 BeiGene Recent Developments/Updates
6.12 Abbvie
6.12.1 Abbvie Corporation Information
6.12.2 Abbvie Anti-PD-1 Antibody Description and Business Overview
6.12.3 Abbvie Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Abbvie Anti-PD-1 Antibody Product Portfolio
6.12.5 Abbvie Recent Developments/Updates
6.13 TG Therapeutics, Inc
6.13.1 TG Therapeutics, Inc Corporation Information
6.13.2 TG Therapeutics, Inc Anti-PD-1 Antibody Description and Business Overview
6.13.3 TG Therapeutics, Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.13.4 TG Therapeutics, Inc Anti-PD-1 Antibody Product Portfolio
6.13.5 TG Therapeutics, Inc Recent Developments/Updates
6.14 Novartis
6.14.1 Novartis Corporation Information
6.14.2 Novartis Anti-PD-1 Antibody Description and Business Overview
6.14.3 Novartis Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Novartis Anti-PD-1 Antibody Product Portfolio
6.14.5 Novartis Recent Developments/Updates
6.15 Arcus Biosciences
6.15.1 Arcus Biosciences Corporation Information
6.15.2 Arcus Biosciences Anti-PD-1 Antibody Description and Business Overview
6.15.3 Arcus Biosciences Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Arcus Biosciences Anti-PD-1 Antibody Product Portfolio
6.15.5 Arcus Biosciences Recent Developments/Updates
6.16 Sino Biological Inc
6.16.1 Sino Biological Inc Corporation Information
6.16.2 Sino Biological Inc Anti-PD-1 Antibody Description and Business Overview
6.16.3 Sino Biological Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Sino Biological Inc Anti-PD-1 Antibody Product Portfolio
6.16.5 Sino Biological Inc Recent Developments/Updates
6.17 3SBio Inc
6.17.1 3SBio Inc Corporation Information
6.17.2 3SBio Inc Anti-PD-1 Antibody Description and Business Overview
6.17.3 3SBio Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.17.4 3SBio Inc Anti-PD-1 Antibody Product Portfolio
6.17.5 3SBio Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-PD-1 Antibody Industry Chain Analysis
7.2 Anti-PD-1 Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-PD-1 Antibody Production Mode & Process
7.4 Anti-PD-1 Antibody Sales and Marketing
7.4.1 Anti-PD-1 Antibody Sales Channels
7.4.2 Anti-PD-1 Antibody Distributors
7.5 Anti-PD-1 Antibody Customers
8 Anti-PD-1 Antibody Market Dynamics
8.1 Anti-PD-1 Antibody Industry Trends
8.2 Anti-PD-1 Antibody Market Drivers
8.3 Anti-PD-1 Antibody Market Challenges
8.4 Anti-PD-1 Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-PD-1 Antibody Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Anti-PD-1 Antibody Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Anti-PD-1 Antibody Market Competitive Situation by Manufacturers in 2022
Table 4. Global Anti-PD-1 Antibody Sales (Kg) of Key Manufacturers (2018-2024)
Table 5. Global Anti-PD-1 Antibody Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Anti-PD-1 Antibody Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Anti-PD-1 Antibody Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Anti-PD-1 Antibody Average Price (USD/g) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Anti-PD-1 Antibody, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Anti-PD-1 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-PD-1 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of Anti-PD-1 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-PD-1 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-PD-1 Antibody as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-PD-1 Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Anti-PD-1 Antibody Sales by Region (2018-2024) & (Kg)
Table 18. Global Anti-PD-1 Antibody Sales Market Share by Region (2018-2024)
Table 19. Global Anti-PD-1 Antibody Sales by Region (2024-2029) & (Kg)
Table 20. Global Anti-PD-1 Antibody Sales Market Share by Region (2024-2029)
Table 21. Global Anti-PD-1 Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Anti-PD-1 Antibody Revenue Market Share by Region (2018-2024)
Table 23. Global Anti-PD-1 Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Anti-PD-1 Antibody Revenue Market Share by Region (2024-2029)
Table 25. North America Anti-PD-1 Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Anti-PD-1 Antibody Sales by Country (2018-2024) & (Kg)
Table 27. North America Anti-PD-1 Antibody Sales by Country (2024-2029) & (Kg)
Table 28. North America Anti-PD-1 Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Anti-PD-1 Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Anti-PD-1 Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Anti-PD-1 Antibody Sales by Country (2018-2024) & (Kg)
Table 32. Europe Anti-PD-1 Antibody Sales by Country (2024-2029) & (Kg)
Table 33. Europe Anti-PD-1 Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Anti-PD-1 Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Anti-PD-1 Antibody Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Anti-PD-1 Antibody Sales by Region (2018-2024) & (Kg)
Table 37. Asia Pacific Anti-PD-1 Antibody Sales by Region (2024-2029) & (Kg)
Table 38. Asia Pacific Anti-PD-1 Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Anti-PD-1 Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Anti-PD-1 Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Anti-PD-1 Antibody Sales by Country (2018-2024) & (Kg)
Table 42. Latin America Anti-PD-1 Antibody Sales by Country (2024-2029) & (Kg)
Table 43. Latin America Anti-PD-1 Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Anti-PD-1 Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Anti-PD-1 Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Anti-PD-1 Antibody Sales by Country (2018-2024) & (Kg)
Table 47. Middle East & Africa Anti-PD-1 Antibody Sales by Country (2024-2029) & (Kg)
Table 48. Middle East & Africa Anti-PD-1 Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Anti-PD-1 Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Anti-PD-1 Antibody Sales (Kg) by Type (2018-2024)
Table 51. Global Anti-PD-1 Antibody Sales (Kg) by Type (2024-2029)
Table 52. Global Anti-PD-1 Antibody Sales Market Share by Type (2018-2024)
Table 53. Global Anti-PD-1 Antibody Sales Market Share by Type (2024-2029)
Table 54. Global Anti-PD-1 Antibody Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Anti-PD-1 Antibody Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Anti-PD-1 Antibody Revenue Market Share by Type (2018-2024)
Table 57. Global Anti-PD-1 Antibody Revenue Market Share by Type (2024-2029)
Table 58. Global Anti-PD-1 Antibody Price (USD/g) by Type (2018-2024)
Table 59. Global Anti-PD-1 Antibody Price (USD/g) by Type (2024-2029)
Table 60. Global Anti-PD-1 Antibody Sales (Kg) by Application (2018-2024)
Table 61. Global Anti-PD-1 Antibody Sales (Kg) by Application (2024-2029)
Table 62. Global Anti-PD-1 Antibody Sales Market Share by Application (2018-2024)
Table 63. Global Anti-PD-1 Antibody Sales Market Share by Application (2024-2029)
Table 64. Global Anti-PD-1 Antibody Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Anti-PD-1 Antibody Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Anti-PD-1 Antibody Revenue Market Share by Application (2018-2024)
Table 67. Global Anti-PD-1 Antibody Revenue Market Share by Application (2024-2029)
Table 68. Global Anti-PD-1 Antibody Price (USD/g) by Application (2018-2024)
Table 69. Global Anti-PD-1 Antibody Price (USD/g) by Application (2024-2029)
Table 70. Bio X Cell Corporation Information
Table 71. Bio X Cell Description and Business Overview
Table 72. Bio X Cell Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 73. Bio X Cell Anti-PD-1 Antibody Product
Table 74. Bio X Cell Recent Developments/Updates
Table 75. Thermo Fisher Corporation Information
Table 76. Thermo Fisher Description and Business Overview
Table 77. Thermo Fisher Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 78. Thermo Fisher Anti-PD-1 Antibody Product
Table 79. Thermo Fisher Recent Developments/Updates
Table 80. InvivoGen Corporation Information
Table 81. InvivoGen Description and Business Overview
Table 82. InvivoGen Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 83. InvivoGen Anti-PD-1 Antibody Product
Table 84. InvivoGen Recent Developments/Updates
Table 85. BioVision Inc Corporation Information
Table 86. BioVision Inc Description and Business Overview
Table 87. BioVision Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 88. BioVision Inc Anti-PD-1 Antibody Product
Table 89. BioVision Inc Recent Developments/Updates
Table 90. Abcam Corporation Information
Table 91. Abcam Description and Business Overview
Table 92. Abcam Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 93. Abcam Anti-PD-1 Antibody Product
Table 94. Abcam Recent Developments/Updates
Table 95. Bristol-Myers Squibb (BMS) Corporation Information
Table 96. Bristol-Myers Squibb (BMS) Description and Business Overview
Table 97. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 98. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product
Table 99. Bristol-Myers Squibb (BMS) Recent Developments/Updates
Table 100. Merck Corporation Information
Table 101. Merck Description and Business Overview
Table 102. Merck Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 103. Merck Anti-PD-1 Antibody Product
Table 104. Merck Recent Developments/Updates
Table 105. Ono Pharmaceutical Co., Ltd Corporation Information
Table 106. Ono Pharmaceutical Co., Ltd Description and Business Overview
Table 107. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 108. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product
Table 109. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
Table 110. Lilly Corporation Information
Table 111. Lilly Description and Business Overview
Table 112. Lilly Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 113. Lilly Anti-PD-1 Antibody Product
Table 114. Lilly Recent Developments/Updates
Table 115. Chugai Pharmaceutical Co., Ltd Corporation Information
Table 116. Chugai Pharmaceutical Co., Ltd Description and Business Overview
Table 117. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 118. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product
Table 119. Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
Table 120. BeiGene Corporation Information
Table 121. BeiGene Description and Business Overview
Table 122. BeiGene Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 123. BeiGene Anti-PD-1 Antibody Product
Table 124. BeiGene Recent Developments/Updates
Table 125. Abbvie Corporation Information
Table 126. Abbvie Description and Business Overview
Table 127. Abbvie Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 128. Abbvie Anti-PD-1 Antibody Product
Table 129. Abbvie Recent Developments/Updates
Table 130. TG Therapeutics, Inc Corporation Information
Table 131. TG Therapeutics, Inc Description and Business Overview
Table 132. TG Therapeutics, Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 133. TG Therapeutics, Inc Anti-PD-1 Antibody Product
Table 134. TG Therapeutics, Inc Recent Developments/Updates
Table 135. Novartis Corporation Information
Table 136. Novartis Description and Business Overview
Table 137. Novartis Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 138. Novartis Anti-PD-1 Antibody Product
Table 139. Novartis Recent Developments/Updates
Table 140. Arcus Biosciences Corporation Information
Table 141. Arcus Biosciences Description and Business Overview
Table 142. Arcus Biosciences Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 143. Arcus Biosciences Anti-PD-1 Antibody Product
Table 144. Arcus Biosciences Recent Developments/Updates
Table 145. Sino Biological Inc Corporation Information
Table 146. Sino Biological Inc Description and Business Overview
Table 147. Sino Biological Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 148. Sino Biological Inc Anti-PD-1 Antibody Product
Table 149. Sino Biological Inc Recent Developments/Updates
Table 150. 3SBio Inc Corporation Information
Table 151. 3SBio Inc Description and Business Overview
Table 152. 3SBio Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 153. 3SBio Inc Anti-PD-1 Antibody Product
Table 154. 3SBio Inc Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Anti-PD-1 Antibody Distributors List
Table 158. Anti-PD-1 Antibody Customers List
Table 159. Anti-PD-1 Antibody Market Trends
Table 160. Anti-PD-1 Antibody Market Drivers
Table 161. Anti-PD-1 Antibody Market Challenges
Table 162. Anti-PD-1 Antibody Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-PD-1 Antibody
Figure 2. Global Anti-PD-1 Antibody Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Anti-PD-1 Antibody Market Share by Type in 2022 & 2029
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global Anti-PD-1 Antibody Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Anti-PD-1 Antibody Market Share by Application in 2022 & 2029
Figure 8. IHC-P
Figure 9. ICC/IF
Figure 10. WB
Figure 11. Flow Cytometry
Figure 12. ELISA
Figure 13. Global Anti-PD-1 Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Anti-PD-1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 15. Global Anti-PD-1 Antibody Sales (2018-2029) & (Kg)
Figure 16. Global Anti-PD-1 Antibody Average Price (USD/g) & (2018-2029)
Figure 17. Anti-PD-1 Antibody Report Years Considered
Figure 18. Anti-PD-1 Antibody Sales Share by Manufacturers in 2022
Figure 19. Global Anti-PD-1 Antibody Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Anti-PD-1 Antibody Players: Market Share by Revenue in 2022
Figure 21. Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Anti-PD-1 Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Anti-PD-1 Antibody Sales Market Share by Country (2018-2029)
Figure 24. North America Anti-PD-1 Antibody Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Anti-PD-1 Antibody Sales Market Share by Country (2018-2029)
Figure 28. Europe Anti-PD-1 Antibody Revenue Market Share by Country (2018-2029)
Figure 29. Germany Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Anti-PD-1 Antibody Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Anti-PD-1 Antibody Revenue Market Share by Region (2018-2029)
Figure 36. China Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Taiwan Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Philippines Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Anti-PD-1 Antibody Sales Market Share by Country (2018-2029)
Figure 47. Latin America Anti-PD-1 Antibody Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Anti-PD-1 Antibody Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Anti-PD-1 Antibody Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Anti-PD-1 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Anti-PD-1 Antibody by Type (2018-2029)
Figure 57. Global Revenue Market Share of Anti-PD-1 Antibody by Type (2018-2029)
Figure 58. Global Anti-PD-1 Antibody Price (USD/g) by Type (2018-2029)
Figure 59. Global Sales Market Share of Anti-PD-1 Antibody by Application (2018-2029)
Figure 60. Global Revenue Market Share of Anti-PD-1 Antibody by Application (2018-2029)
Figure 61. Global Anti-PD-1 Antibody Price (USD/g) by Application (2018-2029)
Figure 62. Anti-PD-1 Antibody Value Chain
Figure 63. Anti-PD-1 Antibody Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed